Print（PDF/126KB） Nov. 04, 2014 Corporate

Sumitomo Dainippon Pharma Announces Organizational Realignment, and Changes in Executive Officers and Other Key Positions

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada) today announced that the following organizational realignment and changes in Executive Officers and other key positions will take place as of the respective dates shown below:

I. Organizational Realignment (effective December 1, 2014)

Corporate Departments

1. "Global Corporate Management" and "Global Strategy and Business Development" are realigned to "Global Corporate Planning" and "Global Business Development."

Drug Research (Division)

1. "External Innovation Development Office" is created.

Purposes of the creation of Global Business Development Department and External Innovation Development Office:
The Global Business Development Department and the External Innovation Development Office are created for the purposes of promoting and strengthening in-licensing and cooperation for future growth of our Company, in parallel to the drug discovery activities of our own.
The Global Business Development Department will have the global responsibility for M&A's, in- and out-licensing and cooperation in the field of the pharmaceuticals businesses of Sumitomo Dainippon Pharma Group. The newly-created department will encompass Sumitomo Dainippon Pharma in Japan and Sunovion Pharmaceuticals, a subsidiary in the U.S., in a seamless manner. The head of Global Business Development will be based in the U.S.
The External Innovations Development Office will coordinate the Company's activities in the information gathering and evaluation of candidate pharmaceuticals and cutting-edge technologies and promote in-licensing and cooperation opportunities in early stages of clinical studies.

II. Changes in Executive Officers

Changes in the posts assumed by Executive Officers (effective December 1, 2014)

Post as of December 1, 2014	Current post	Name
Member, Board of Directors, Senior Executive Officer Global Corporate Planning; Global Business Development; External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting; Regenerative & Cellular Medicine Office	Member, Board of Directors, Senior Executive Officer Global Corporate Management; Global Strategy & Business Development; External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting; Regenerative & Cellular Medicine Office	Hiroshi Nomura
Executive Officer Executive Vice President, Sunovion Pharmaceuticals Inc.; Director, Global Business Development; Head of Global Business Development for DSP Group	Executive Officer Executive Vice President , Sunovion Pharmaceuticals Inc.	Hiroyuki Baba

III. Changes in Personnel (effective April 1, 2014)

Corporate Departments

Position as of December 1, 2014	Current position	Name
Director, Global Corporate Planning	Director, Global Corporate Management	Hajime Kinuta
Director, Global R&D Office	Director, Global Strategy & Business Development, Global R&D Office	Koichi Kozuki
Director, Global Oncology Office	Group Manager, Global Strategy Group, Global Oncology Office	Yasushi Matuski

Drug Research (Division)

Position as of December 1, 2014	Current position	Name
Deputy Executive Director, Drug Research Director, External Innovation Development Office	Deputy Executive Director, Drug Research Director, Global Oncology Office	Shigeyuki Nishinaka